The FDA refused to review Moderna’s application for a new flu vaccine, the company said yesterday. It’s a surprising decision that could raise concerns about the agency’s posture toward drug companies ...

In a rare and surprising move, the FDA has issued a “Refusal to File” letter for Moderna’s mRNA-1010 influenza vaccine.

The COVID-19 pandemic highlighted an urgent need for efficient, durable, and widely accessible vaccines. This prompted several important innovations in vaccine technology, and researchers continue to ...

Pfizer (NYSE: PFE) posted fourth-quarter 2025 revenue of about $18 billion, down 1% from the year-ago quarter, and adjusted ...

Here’s how the candidates responded to Star-Telegram questions about why they deserve your vote in the March 3 primary.

After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.

Which of the highest-yielding healthcare stocks are value traps or golden opportunities?

A health care tool for an overlooked public health problemFear of needles is one of health care’s most common, and most ...

Australian parents are boasting about paying anti-vaccine nurses to falsify Medicare records of their children, putting lives at risk, an investigation has revealed.

US mRNA specialist Moderna’s edged up 2.7% this morning as it announced it has signed a Memorandum of Understanding (MoU) for a long-term strategic agreement with the Mexican Government, Laboratorios ...

Oral vaccines promise painless, needle-free protection—but the human gut evolved to destroy exactly what vaccines are made of ...

The biggest changes to the US child vaccination schedule for decades have been announced by the country's Centers for Disease Control and Prevention (CDC), having been authorised by US Health and ...